Micro-dosing GLP-1/GIP RA in ME/CFS & Long Covid. Clinician's Roundtable with Drs. Kaufman & Dempsey
Автор: Renegade Research
Загружено: 2025-10-18
Просмотров: 1952
Renegade Research Clinician's Roundtable with David Kaufman, MD, and Tania Dempsey, MD, sharing clinical experience in using small doses of GLP1/GIP Receptor Agonists in ME/CFS and Long Covid.
0:00:00 Opening of Zoom Room
0:00:28 Welcome and Announcements
0:02:10 Dr. Kaufman and Dr. Dempsey Discuss GLP-1/GIP RA
including tirzepatide and semaglutide
0:13:10 Q. Any similarities in the patients that are responding?
0:26:12 How do you make the decision to prescribe this medication and the dose?
0:48:45 Stuart Malcolm, MD, joins the discussion
0:57:40 What would you say to clinicians who want to learn to use these meds with pts
1:03:17 Audience Q&A
1:03:23 Use under age 18?
1:05:06 Increase in Appetite?
1:08:39 Any identifying predictors of + or - responses?
1:21:02 Will RECOVER TLC clinical trial use micro or standard dose GLP-1
1:23:24 How decide which drug to start with a particular patient?
1:30:00 Close
This roundtable was covered by CortJohnson in a Health Rising post on Nov 3, 2025:
"The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway"
https://healthrising.org/blog/2025/11...
Announcements for this event with speaker info, links to their previous roundtables, and more https://docs.google.com/document/d/1q...
To sign up for Renegade Research newsletter, go to https://renegade-research.org/join-em...
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
